BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11856253)

  • 1. Should all stool specimens be routinely tested for Clostridium difficile?
    Bourgault AM; Yechouron A; Gaudreau C; Gilbert H; Lamothe F
    Clin Microbiol Infect; 1999 Apr; 5(4):219-223. PubMed ID: 11856253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000.
    Voetsch AC; Angulo FJ; Rabatsky-Ehr T; Shallow S; Cassidy M; Thomas SM; Swanson E; Zansky SM; Hawkins MA; Jones TF; Shillam PJ; Van Gilder TJ; Wells JG; Griffin PM;
    Clin Infect Dis; 2004 Apr; 38 Suppl 3():S190-7. PubMed ID: 15095189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features.
    Slutsker L; Ries AA; Greene KD; Wells JG; Hutwagner L; Griffin PM
    Ann Intern Med; 1997 Apr; 126(7):505-13. PubMed ID: 9092315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile and cytotoxin in routine faecal specimens.
    Nash JQ; Chattopadhyay B; Honeycombe J; Tabaqchali S
    J Clin Pathol; 1982 May; 35(5):561-5. PubMed ID: 7085901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of routine enteric pathogens in hospitalized patients: A Canadian perspective.
    Gough K; Alfa M; Harding G
    Can J Infect Dis; 1996 May; 7(3):197-202. PubMed ID: 22514438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease.
    Gurian L; Klein K; Ward TT
    West J Med; 1983 Mar; 138(3):359-60. PubMed ID: 6858121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients.
    Predrag S; Branislava K; Miodrag S; Biljana MS; Suzana T; Natasa MT; Tatjana B
    Braz J Microbiol; 2012 Jan; 43(1):215-23. PubMed ID: 24031820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study.
    Klein EJ; Boster DR; Stapp JR; Wells JG; Qin X; Clausen CR; Swerdlow DL; Braden CR; Tarr PI
    Clin Infect Dis; 2006 Oct; 43(7):807-13. PubMed ID: 16941358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study.
    Barbut F; Day N; Bouée S; Youssouf A; Grandvoinnet L; Lalande V; Couturier J; Eckert C
    Clin Microbiol Infect; 2019 May; 25(5):588-594. PubMed ID: 30616013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological agents of infectious diarrhea: implications for requests for microbial culture.
    Rohner P; Pittet D; Pepey B; Nije-Kinge T; Auckenthaler R
    J Clin Microbiol; 1997 Jun; 35(6):1427-32. PubMed ID: 9163457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine detection of Clostridium difficile in Western Australia.
    Collins DA; Riley TV
    Anaerobe; 2016 Feb; 37():34-7. PubMed ID: 26592987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of culture in the diagnosis of Clostridium difficile infection.
    Bond F; Payne G; Borriello SP; Humphreys H
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):223-6. PubMed ID: 7614964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients: a case-control study--sucralfate ingestion is not a negative risk factor.
    Watanakunakorn PW; Watanakunakorn C; Hazy J
    Infect Control Hosp Epidemiol; 1996 Apr; 17(4):232-5. PubMed ID: 8935731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea.
    Peterson LR; Olson MM; Shanholtzer CJ; Gerding DN
    Diagn Microbiol Infect Dis; 1988 Jun; 10(2):85-91. PubMed ID: 3066571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal methods for identifying Clostridium difficile infections.
    Gerding DN; Brazier JS
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S439-42. PubMed ID: 8324164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.